相似文献
1
The role of HPV in head and neck cancer and review of the HPV vaccine.
Prev Med. 2011 Oct;53 Suppl 1(Suppl 1):S5-S11. doi: 10.1016/j.ypmed.2011.08.001.
2
HPV vaccination in head and neck HPV-related pathologies.
Otolaryngol Pol. 2014 Jul-Aug;68(4):157-73. doi: 10.1016/j.otpol.2014.05.004. Epub 2014 Jun 3.
3
Prophylactic human papilloma virus vaccination in head and neck: indications and future perspectives.
Curr Opin Otolaryngol Head Neck Surg. 2019 Apr;27(2):85-90. doi: 10.1097/MOO.0000000000000525.
4
Human papillomavirus (HPV) vaccine and HPV-related head and neck cancer: What's next?
Oral Oncol. 2019 Jun;93:125-126. doi: 10.1016/j.oraloncology.2019.04.001. Epub 2019 Apr 5.
5
[Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Klin Onkol. 2014;27(4):239-46. doi: 10.14735/amko2014239.
6
Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
Acta Med Port. 2020 Mar 2;33(3):198-201. doi: 10.20344/amp.12259.
7
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.
J Clin Oncol. 2015 Oct 10;33(29):3235-42. doi: 10.1200/JCO.2015.61.6995. Epub 2015 Sep 8.
8
Developments in L2-based human papillomavirus (HPV) vaccines.
Virus Res. 2017 Mar 2;231:166-175. doi: 10.1016/j.virusres.2016.11.020. Epub 2016 Nov 23.
9
The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Front Immunol. 2020 Feb 18;11:188. doi: 10.3389/fimmu.2020.00188. eCollection 2020.
10
Indications and efficacy of the human papillomavirus vaccine.
Curr Treat Options Oncol. 2007 Dec;8(6):393-401. doi: 10.1007/s11864-007-0050-0.
引用本文的文献
1
Intervention Strategies to Overcome HPV Vaccine Hesitancy Among Hispanic Immigrants in the USA: A Video-Based Approach.
Vaccines (Basel). 2025 May 28;13(6):574. doi: 10.3390/vaccines13060574.
2
Immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: PD-L1 and beyond.
Pathologica. 2025 Apr;117(2):73-83. doi: 10.32074/1591-951X-1092.
3
Human Papillomavirus: A Narrative Review for Dental Providers in Prevention and Care.
Int J Environ Res Public Health. 2025 Mar 17;22(3):439. doi: 10.3390/ijerph22030439.
4
Expression rates of p16, p53 in head and neck cutaneous squamous cell carcinoma based on human-papillomavirus positivity.
World J Clin Cases. 2025 Mar 26;13(9):99463. doi: 10.12998/wjcc.v13.i9.99463.
5
Prevalence of Human Papillomavirus-Associated Head and Neck Cancer in Rwanda: A 10-Year Review.
Cancer Med. 2024 Nov;13(21):e70423. doi: 10.1002/cam4.70423.
6
Association between tonsillectomy and risk of oropharyngeal cancer: a systematic review.
Acta Otorhinolaryngol Ital. 2024 Jun;44(3):143-149. doi: 10.14639/0392-100X-N2790. Epub 2024 May 3.
7
HPV related p16 and HSV in benign and potentially malignant oral mucosa pathologies.
BMC Oral Health. 2024 Mar 18;24(1):347. doi: 10.1186/s12903-024-04105-z.
8
Geographic variation of HPV-associated cancer incidence in Kentucky using spatial scan statistics.
Cancer Causes Control. 2024 May;35(5):817-824. doi: 10.1007/s10552-023-01835-3. Epub 2024 Jan 12.
9
Human Papilloma Virus-Infected Cells.
Subcell Biochem. 2023;106:213-226. doi: 10.1007/978-3-031-40086-5_8.
10
Preventive health behaviors among the middle-aged and elderly in China: Does social capital matter?
Prev Med Rep. 2023 Jul 20;35:102329. doi: 10.1016/j.pmedr.2023.102329. eCollection 2023 Oct.
本文引用的文献
1
Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
J Clin Oncol. 2011 Nov 10;29(32):4294-301. doi: 10.1200/JCO.2011.36.4596. Epub 2011 Oct 3.
2
Oral human papillomavirus infection in women with cervical HPV infection: new data from an Italian cohort and a metanalysis of the literature.
Oral Oncol. 2011 Apr;47(4):244-50. doi: 10.1016/j.oraloncology.2011.02.011.
3
Prevalence of heavy smoking in California and the United States, 1965-2007.
JAMA. 2011 Mar 16;305(11):1106-12. doi: 10.1001/jama.2011.334.
4
Trends in human immunodeficiency virus- and sexually transmitted disease-related risk behaviors among U.S. high school students, 1991-2009.
Am J Prev Med. 2011 Apr;40(4):427-33. doi: 10.1016/j.amepre.2010.12.010.
5
Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study.
Lancet. 2011 Mar 12;377(9769):932-40. doi: 10.1016/S0140-6736(10)62342-2. Epub 2011 Feb 28.
6
Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines.
Hum Vaccin. 2011 Feb;7(2):161-9. doi: 10.4161/hv.7.2.13690. Epub 2011 Feb 1.
7
Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.
N Engl J Med. 2011 Feb 3;364(5):401-11. doi: 10.1056/NEJMoa0909537.
8
Focus on research: weighing the benefits and costs of HPV vaccination of young men.
N Engl J Med. 2011 Feb 3;364(5):393-5. doi: 10.1056/NEJMp1012246.
9
Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers.
Br J Cancer. 2011 Mar 1;104(5):886-91. doi: 10.1038/sj.bjc.6606091. Epub 2011 Feb 1.
10
Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis.
BMC Infect Dis. 2011 Jan 12;11:13. doi: 10.1186/1471-2334-11-13.
Zotero 插件